Notícias e Atividades da F-Star Biotechnology
Presença
F-Star Biotechnology pertence à InvoX Pharma.
InvoX Pharma tem presença direta em 2 países.
Eles estão dentro:
- Biotecnologia67%
- Farmacêutica33%
Executivos
Veja o organograma con seus 5 executivos principais
Biografias mais buscadas da F-Star Biotechnology
- Neil Brewis, Chief Scientific Officer, Chief Executive Officer and...
- Pauline Stevens, Head of Business Operations
- Katy Everett, Head of Discovery
Recentes movimentos de executivos em InvoX Pharma
- Tyron Hussey, Head of Legal and Compliance, deixou a Companhia (Notícia publicada em 15 de abril de 2025).
- Michelle Morrow, Head of Therapeutic Innovation, deixou a Companhia (Notícia publicada em 16 de outubro de 2024).
Criar um alerta
para seguir os movimentos de executivos da F-Star Biotechnology.
Biotecnologia
InvoX Pharma possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Genus (Reino Unido).
Popular M&A news in Biotecnologia
- Transcarent and Accolade have merged (publicado em 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de F-Star Biotechnology
- F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies - F-Star Therapeutics Inc.
- invoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc. | F-star Therapeutics, Inc.
- F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody | F-star Therapeutics, Inc.
- invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs | F-star Therapeutics, Inc.
- F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update | F-star Therapeutics, Inc.
- F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022 | F-star Therapeutics, Inc.
- F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022 | F-star Therapeutics, Inc.
- F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update | F-star Therapeutics, Inc.
- F-star Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference | F-star Therapeutics, Inc.
- F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022 | F-star Therapeutics, Inc.
- View more press releases Close
Redes sociais sobre F-Star Biotechnology
- F-Star Biotechnology na Wikipedia, Google News e Yahoo Finance
- F-Star Biotechnology na LinkedIn, Twitter e YouTube
